Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
A. Babichev
Observed names:
A V Babichev,
A. N. Babichev,
А. В. Бабичев
Institutions:
Pirogov Russian National Research Medical University,
Ministry of Health of the Russian Federation
Observed institutions:
Pirogov Russian National Research Medical University,
Ministry of Health of the Russian Federation
ORCID:
0009-0001-4826-3411
Observed ORCID:
0009-0001-4826-3411
OpenAlex ID:
A5058475843
Ways to increase freedom from DOAC-dependent complications in elderly patients with polypharmacy and chronic kidney disease: molecular and genetic aspects
2025
·
A. Kondrahin
, E. Silina
, et al.
·
Molekulyarnaya Meditsina (Molecular medicine)
·
1
Polypragmasy in elderly and senile patients with chronic kidney disease: START/STOP criteria in elderly and senile patients taking DOAC
2025
·
A. Kondrahin
, E. Silina
, et al.
·
Molekulyarnaya Meditsina (Molecular medicine)
Efficacy and safety of omalizumab for children and adolescents with atopic dermatitis (Literature review)
2025
·
K. O. Shnaider
, A. P. Kondrakhin
, et al.
·
Glavvrač (Chief Medical Officer)
Группы крови в прогнозировании и донозологической диагностике заболеваний
2007
·
В. М. Радомская
, О Ю Кузнецова
, et al.
·
Вятский медицинский вестник
[Chronic fatigue syndrome:objective criteria of metabolic defects].
1999
·
F N Gil'miiarova
, V M Radomskaia
, et al.
·
PubMed
Show more works
View as search
Works count:
5
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type